Next Article in Journal
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Next Article in Special Issue
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
Previous Article in Journal
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration
Previous Article in Special Issue
Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis
 
 
Article

Article Versions Notes

Cancers 2021, 13(16), 4112; https://doi.org/10.3390/cancers13164112
Action Date Notes Link
article xml file uploaded 15 August 2021 14:03 CEST Original file -
article xml uploaded. 15 August 2021 14:03 CEST Update https://www.mdpi.com/2072-6694/13/16/4112/xml
article pdf uploaded. 15 August 2021 14:03 CEST Version of Record https://www.mdpi.com/2072-6694/13/16/4112/pdf
article supplementary file uploaded. 15 August 2021 14:03 CEST - https://www.mdpi.com/2072-6694/13/16/4112#supplementary
article html file updated 15 August 2021 14:04 CEST Original file -
article html file updated 28 July 2022 06:07 CEST Update https://www.mdpi.com/2072-6694/13/16/4112/html
Back to TopTop